This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Schafer-N, Universitaetsklinikum Hamburg-Eppendorf. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 2 
2 out of 7 Years Active: 2008-2011
Title: Innovations of Claus Schafer Nielsen
Introduction
Claus Schafer Nielsen is a notable inventor based in Humlebaek, Denmark. He has made significant contributions to the field of biomedical research, particularly in the modulation of neural cell adhesion molecule (NCAM) functions. With a total of 2 patents, his work focuses on innovative approaches to treat neurodegenerative diseases and related conditions.
Latest Patents
Nielsen's latest patents include the use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions. The first patent describes a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues. This peptide comprises a B epitope of a poly-α2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-α2,8 sialic acid (PSA) antibody. The invention aims to prepare a medicament for modulating NCAM functions, which can be administered for the prevention and/or treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer. The second patent reiterates similar findings and applications, emphasizing the importance of these peptides in medical treatments.
Career Highlights
Throughout his career, Claus Schafer Nielsen has worked with prestigious organizations, including the Centre National De La Recherche Scientifique and Schafer-n. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Nielsen has collaborated with notable colleagues such as Pascal Torregrossa and Melitta Schachner. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Claus Schafer Nielsen's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches to treating neurodegenerative diseases and related conditions demonstrate the potential impact of his work on future therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile